Day: January 3, 2022

Ascletis Expands Ritonavir Oral Tablet Production and Announces Oral Direct-Acting Antiviral Pipeline Against SARS-CoV-2 Virus

– Ritonavir oral tablet annual production capacity has been expanded to 100 million tablets and can be further rapidly expanded based on market demand

– ASC10 is an oral direct-acting antiviral drug candidate targeting RNA dependent RNA polymerase (RdRp) to treat SARS-CoV-2 infection

– ASC11 is an oral direct-acting antiviral

Fears for Australia’s Famous Migrating Moth

Conservationists are blaming climate change, land clearing and pesticides for the population crash of one of Australia’s most famous insects. Once a common sight, bogong moths have become rare in recent years. They are now recognized as endangered by the world’s leading scientific authority on vulnerable species, the International Union …

Back To Top